跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目3026-3050 / 13423. (共537頁) << < 117 118 119 120 121 122 123 124 125 126 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2000-02	Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis	Carcinogenesis. 2000 Feb;21(2):331-335.
2021-04-16	Curcumin-loaded hydrophobic surface-modified hydroxyapatite as an antioxidant for sarcopenia prevention	Antioxidants. 2021 Apr 16;10(4):Article number 616.
2018-03	Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy	Journal of Cancer Research and Practice. 2018 Mar;5(1):27-31.
2021-10-22	Cure the incurable? Recent breakthroughs in immune checkpoint blockade for hepatocellular carcinoma	Cancers. 2021 Oct 22;13(21):Article number 5295.
2011-06	Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein	Current Topics In Medicinal Chemistry. 2011 Jun;(11):1447-1463.
2024-07-27	Current advances of oral cancer in Taiwan	Oral Diseases. 2024 Jul 27;Article in Press.
2022-04-19	Current and developing liquid biopsy techniques for breast cancer	Cancers. 2022 Apr 19;14(9):Article number 2052.
2012-05	Current applications of human pluripotent stem cells: Possibilities and challenges	Cell Transplantation. 2012 May;21(5):801-814.
1998-06	Current outlook of infectious diseases in Taiwan	Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 1998 Jun;31(2):73-83.
2020-06	Current practice patterns and training project of oral pathology specialists in Taiwan	Journal of Dental Sciences. 2020 Jun;15(2):168-175.
2006-12	Current progress in dendritic cell research	Journal of Cancer Molecules. 2006 Dec;2(6):217-220.
2023-08	Current role and potential of polymeric biomaterials in clinical obesity treatment	Biomacromolecules. 2023 Aug 14;24(8):3438-3449.
2004-09	Current status of clinical studies for colorectal cancer in Taiwan	Clinical Colorectal Cancer. 2004 Sep;4(3):196-203.
2020-10	Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19	Stem Cells Translational Medicine. 2020 Oct;9(10):1163-1173.
2003-12	The current status of smoking behavior in Taiwan: Data analysis from National Health Interview Survey in 2001	Taiwan Journal of Public Health. 2003 Dec;22(6):453-464.
2022-02-16	Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma	Cancers. 2022 Feb 16;14(4):Article number 1005.
2019-08-21	Current understanding of the gut microbiota shaping mechanisms	Journal of Biomedical Science. 2019 Aug 21;26(1):Article number 59.
2019-07	Cutoff values of acoustic radiation force impulse two-location measurements in different etiologies of liver fibrosis	Journal of Medical Ultrasound. 2019 Jul-Sep;27(3):130-134.
2013-10	The cutoff values of the grip strength and gait speed for discriminating community- dwelling older adults with/without IADL or ADL disability	2013年公衛聯合年會. 2013 Oct:71.
2020-10-22	CUX2, BRAP and ALDH2 are associated with metabolic traits in people with excessive alcohol consumption	Scientific Reports. 2020 Oct 22;10:Article number 18118.
2017-03	CXCL12/CXCR4 signaling contributes to the pathogenesis of opioid tolerance: A translational study	Anesthesia and Analgesia. 2017 Mar;124(3):972-979.
2015-07-15	CXCR4 antagonist TG-0054 mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction	Cell Transplantation. 2015 Jul 15;24(7):1313-1328.
2025-03-10	CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma	Journal of Controlled Release. 2025 Mar 10;379:967-981.
2018-12	CXCR44 antagonist reduced the incidence of acute rejection and controlled cardiac allograft vasculopathy in a swine heart transplant model receiving a mycophenolate-based immunosuppressive regimen	Transplantation. 2018 Dec;102(12):2002-2011.
2024-06-19	CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity	Cell Death and Disease. 2024 Jun 19;15(6):Article number 434.

顯示項目3026-3050 / 13423. (共537頁) << < 117 118 119 120 121 122 123 124 125 126 > >> 每頁顯示[10|25|50]項目